Interleukin-4 in chronic myelomonocytic leukemia. Growth suppression of hematopoietic precursors in the chronic phase and stimulation in the acute phase

Acta Haematol. 1994;92(2):104-8. doi: 10.1159/000204191.

Abstract

We examined the effects of interleukin-4 (IL-4) on the growth of hematopoietic precursors from a patient with chronic myelomonocytic leukemia (CMMoL). In the chronic phase of the disease, IL-4 inhibited spontaneous colony formation by CMMoL cells in semi-solid culture. However, in the acute phase, IL-4 promoted colony formation. These effects of IL-4 were abolished completely by the addition of anti-IL-4 neutralizing antibodies. The spontaneous colony formation by CMMoL cells in both the chronic and acute phases was inhibited by the addition of anti-IL-6 antibodies. On the other hand, neither anti-IL-6, anti-granulocyte macrophage colony-stimulating factor (GM-CSF), anti-IL-1 beta nor anti-tumor necrosis factor alpha (TNF alpha) antibodies inhibited IL-4-induced colony formation by CMMoL cells in the acute phase. IL-4 suppressed the production of IL-6 by CMMoL cells in both the chronic and acute phases. These results suggest that in the present patient, IL-4 suppressed the IL-6-mediated autocrine growth of CMMoL cells in both the chronic and acute phases, but directly stimulated their growth in the acute phase.

Publication types

  • Case Reports
  • Comparative Study
  • Review

MeSH terms

  • Antibodies / pharmacology
  • Bone Marrow / pathology
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Interleukin-4 / immunology
  • Interleukin-4 / pharmacology*
  • Interleukin-6 / immunology
  • Interleukin-6 / pharmacology
  • Leukemia, Myelomonocytic, Acute / pathology*
  • Leukemia, Myelomonocytic, Chronic / pathology*
  • Male
  • Middle Aged
  • Neutralization Tests

Substances

  • Antibodies
  • Interleukin-6
  • Interleukin-4